EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serum levels of IL-9 and IL-11 serve as predictors for the occurrence of early neurologic deterioration in patients with cerebral infarction

Xianglin Guo, Xiaoyan Zhu, Shuai Zhou, Xiaohong Dong

Clinica Chimica Acta · 2024

DOI: 10.1016/j.cca.2024.119683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2024. Verfasst von Xianglin Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, People's Hospital of Yangzhong City, Yangzhong, Jiangsu 212200, China. Hauptthemen laut MEDLINE: Cerebral Infarction, Interleukin-11, Interleukin-9. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Early neurological deterioration (END) is a common complication of cerebral infarction and a significant contributor to poor prognosis. Our study aimed to investigate the predictive value of interleukin-9 (IL-9) and interleukin-11 (IL-11) in relation to the occurrence of END in patients with cerebral infarction. MATERIALS AND METHODS: 102 patients with cerebral infarction and 64 healthy controls were collected. Patients were categorized into two groups based on the development of END following admission: the END group (n = 44) and the non-END group (n = 58). Enzyme-linked immunosorbent assay was used to determine the serum levels of IL-9, IL-11, and BDNF. RESULTS: Serum IL-9 was higher and IL-11 lower in the END group than those in the non-END group (P < 0.01). IL-9 correlated positively with NIHSS score (r = 0.627) and infarction volume (r = 0.686), while IL-11 correlated negatively (r = -0.613, -0.679, respectively). Logistic regression identified age, NIHSS score, and IL-9 as risk factors (P < 0.01), and IL-11 as protective (P < 0.01). Combined IL-9 and IL-11 had an ROC curve area of 0.849. BDNF correlated negatively with IL-9 (r = -0.703) and positively with IL-11 (r = 0.711). CONCLUSION: Serum IL-9 and IL-11 levels can predict the occurrence of END in patient with cerebral infarction and are correlated with serum BDNF levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral InfarctionInterleukin-11Interleukin-9HumansMaleFemaleAgedMiddle AgedBrain-Derived Neurotrophic FactorCase-Control StudiesPrognosis

Stichwörter der Autor:innen

Cerebral infarctionEarly neurological deteriorationInterleukin-11Interleukin-9

Substanzen

Interleukin-11Interleukin-9IL11 protein, humanBrain-Derived Neurotrophic FactorIL9 protein, human

Autor:innen und Institutionen

  • Department of Emergency, People's Hospital of Yangzhong City, Yangzhong, Jiangsu 212200, China.
  • Department of Neurology, People's Hospital of Yangzhong City, Yangzhong, Jiangsu 212200, China; School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, Jiangsu 225000, China; Jiangsu Key Laborator…
  • Department of Neurology, The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222002, China. Electronic address: dongxh2024@163.com.

Zitieren

APA

Guo, X., Zhu, X., Zhou, S., & Dong, X. (2024). Serum levels of IL-9 and IL-11 serve as predictors for the occurrence of early neurologic deterioration in patients with cerebral infarction. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.119683

Vancouver

Guo X, Zhu X, Zhou S, Dong X. Serum levels of IL-9 and IL-11 serve as predictors for the occurrence of early neurologic deterioration in patients with cerebral infarction. Clinica Chimica Acta. 2024. doi:10.1016/j.cca.2024.119683

BibTeX
@article{Guo2024,
  author = {Guo, Xianglin and Zhu, Xiaoyan and Zhou, Shuai and Dong, Xiaohong},
  title = {Serum levels of IL-9 and IL-11 serve as predictors for the occurrence of early neurologic deterioration in patients with cerebral infarction},
  journal = {Clinica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.cca.2024.119683}
}
Kostenlos starten →